No,구분,개별,평가의뢰일,평가의뢰기관,재평가,평가의뢰종목,법인번호,평가종류,회차,민감도,주기,기준일,평가값송부일,보고서송부일,민감도송부일,평가담당자,공수,전기평가,RM,결과보고서송부,등록월,등록그룹,담당자,연락처,Mail,평가목적,종목등록일
253,-,기초자산,한국투자증권(M&A/인수금융2부)펀드(기초자산),마이다스제8호사모투자,재평가,"아이엠티씨(구,비긴바이오)",1801110875336 ,A07,0,-,분기 ,2024.09.30,2024-10-04,보고서제공X,-,강성은, 0.4 ,강성은,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
812,-,기초자산,한화생명보험펀드(기초자산),스톤브릿지한국형유니콘투자조합,재평가,"17Live Inc(구,M17 Entertainment Limited)",KBP2018060018,A01,0,-,분기,2024.09.30,2024-09-13,보고서제공X,-,김영하, - ,김영하,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
2126,-,기초자산,교보생명보험펀드(기초자산),퓨처플레이신한테크이노베이션제2호,재평가,넥스클라우드,1101115638717 ,D02,0,-,분기,2024.09.30,평가철회,평가철회,-,김에스더, - ,김범준,-,-,평가철회,평가철회,0,0,0,-,0
2419,-,기초자산,MG손해보험펀드(기초자산),비티에스제1호사모투자,재평가,아폴로,2001110447990 ,D02,1,-,분기 ,2024.09.30,평가철회,평가철회,-,조현우, - ,조현우,-,-,평가철회,평가철회,0,0,0,-,0
2422,-,기초자산,MG손해보험펀드(기초자산),비티에스제1호사모투자,재평가,아폴로,2001110447990 ,D02,4,-,분기 ,2024.09.30,평가철회,평가철회,-,조현우, - ,조현우,-,-,평가철회,평가철회,0,0,0,-,0
2476,"가평가값 : 2024-09-10(퇴근전), 최종가격 : 2024-10-04, 민감도/듀레이션 : 2024-10-11",개별종목,2024-08-29,KB손해보험,재평가,현대유퍼스트사모부동산투자신탁18-2호,KBP2016120122,B02,0,Y,분기,2024.09.30,평가철회,평가철회,평가철회,대체평가3사업본부, - ,대체평가3사업본부,정은채/김태현,정은채/김태현,평가철회,평가철회,자산운용기획부정호우주임,02-6913-3051,jieun1977@kbinsure.co.kr,가평가,0
3762,-,기초자산,신영증권펀드(기초자산),SGI퍼스트펭귄스타트업펀드,재평가,"파트론이에스엘(구,라인어스)",1358110248336 ,A01,0,-,분기,2024.09.30,2024-10-04,보고서제공X,-,이상민, 0.4 ,이상민,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
4079,-,개별종목,2024-09-04,키움증권(수익증권),재평가,보고SS일반사모투자신탁2호,KBP2023120066,B02,0,Y,분기 ,2024.09.30,평가철회,평가철회,평가철회,대체평가3사업본부, - ,대체평가3사업본부,김본,김본,평가철회,평가철회,재무팀이학인과장,02-3787-9741 ,hokijo@kiwoom.com; clark@kiwoom.com; jskim9900@kiwoom.com ,-,0
4301,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,"오럼머티리얼(구,티지오테크)",1348110144444 ,A07,6,-,분기,2024.09.30,2024-10-07,보고서제공X,-,이상민, 0.4 ,고명주,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
4366,-,개별종목,2024-09-06,아이씨엠,재평가,아이씨엠,1101114963058 ,A01,0,-,미정,2024.04.01,평가철회,평가철회,-,김수현, - ,김수현,김수현,김수현,평가철회,평가철회,조선혜과장,02-324-8562,seonhae.cho@icm-bio.com,회계반영,0
4367,-,개별종목,2024-09-06,아이씨엠,재평가,아이씨엠,1101114963058 ,D06,9,-,미정,2024.04.01,평가철회,평가철회,-,김수현, - ,김수현,김수현,김수현,평가철회,평가철회,조선혜과장,02-324-8562,seonhae.cho@icm-bio.com,회계반영,0
4545,-,개별종목,2024-09-09,아이씨엠,재평가,아이씨엠,1101114963058 ,D06,11,-,미정,2024.12.31,평가철회,평가철회,-,김수현, - ,김수현,김수현,김수현,평가철회,평가철회,조선혜과장,02-324-8562,seonhae.cho@icm-bio.com,회계반영,0
4546,-,개별종목,2024-09-09,아이씨엠,재평가,아이씨엠,1101114963058 ,D06,12,-,미정,2024.12.31,평가철회,평가철회,-,김수현, - ,김수현,김수현,김수현,평가철회,평가철회,조선혜과장,02-324-8562,seonhae.cho@icm-bio.com,회계반영,0
4547,-,개별종목,2024-09-09,아이씨엠,재평가,아이씨엠,1101114963058 ,D06,2,-,미정,2024.12.31,평가철회,평가철회,-,김수현, - ,김수현,김수현,김수현,평가철회,평가철회,조선혜과장,02-324-8562,seonhae.cho@icm-bio.com,회계반영,0
4548,-,개별종목,2024-09-09,아이씨엠,재평가,아이씨엠,1101114963058 ,D06,31,-,미정,2024.12.31,평가철회,평가철회,-,김수현, - ,김수현,김수현,김수현,평가철회,평가철회,조선혜과장,02-324-8562,seonhae.cho@icm-bio.com,회계반영,0
4549,-,개별종목,2024-09-09,아이씨엠,재평가,아이씨엠,1101114963058 ,D06,32,-,미정,2024.12.31,평가철회,평가철회,-,김수현, - ,김수현,김수현,김수현,평가철회,평가철회,조선혜과장,02-324-8562,seonhae.cho@icm-bio.com,회계반영,0
4550,-,개별종목,2024-09-09,아이씨엠,재평가,아이씨엠,1101114963058 ,D06,4,-,미정,2024.12.31,평가철회,평가철회,-,김수현, - ,김수현,김수현,김수현,평가철회,평가철회,조선혜과장,02-324-8562,seonhae.cho@icm-bio.com,회계반영,0
5419,-,기초자산,현대해상수익증권(기초자산),파인밸류메자닌플러스F,신규,"달바글로벌(구,비모뉴먼트)",1101115995993 ,A01,0,-,분기 ,2024.09.30,2024-10-04,보고서제공X,-,김에스더, - ,김에스더,-,-,202409,[U]기타보험기관(기초자산),0,0,0,-,0
5420,-,기초자산,한화생명보험펀드(기초자산),스톤브릿지한국형유니콘투자조합,재평가,스페이스워크,1101116141959 ,A01,0,-,분기,2024.09.30,2024-09-13,보고서제공X,-,최수민, - ,최수민,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5421,-,개별종목,2024-09-30,에이비엘바이오,재평가,에이비엘바이오,1101115974020 ,A05,0,-,분기,2024.09.30,2024-10-10,2024-10-17,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,김지용수석,010-7272-4202,jiyong.kim@ablbio.com,회계반영,0
5422,-,개별종목,2024-09-30,에이비엘바이오,재평가,에이비엘바이오,1101115974020 ,D06,0,-,분기,2024.09.30,2024-10-10,2024-10-17,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,김지용수석,010-7272-4202,jiyong.kim@ablbio.com,회계반영,0
5423,-,개별종목,2024-09-30,브레인자산운용,재평가,무신사,1101114898916 ,A01,0,-,미정,2024.06.30,2024-10-10,2024-10-10,-,이문수, - ,이문수,-,-,202406,[Y]금융기관,심연정부장,02-6277-5069,yj.shim@brainib.com,회계반영,0
5424,-,개별종목,2024-09-30,유진투자증권,신규,한국경제신문,1101110042426 ,A01,0,-,미정,2024.09.30,2024-10-10,2024-10-16,-,강승현, 1.0 ,강승현,-,-,202409,[Y]금융기관,박미경부부장,02-368-6237,mikpark@eugenefn.com,매매검토 목적,0
